相关实验视频
Updated: Jan 15, 2026

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.9K
通过调节巨细胞,HSPA1A可以缓解CFA诱导的炎症性疼痛
Wenjie Zhang1, Xiaojun Xie1, Xiaomin Xiong1
1School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 510000, China.
International journal of molecular sciences
|October 16, 2025
概括
热冲击蛋白家族A成员1A (HSPA1A) 通过调节巨细胞代谢来缓解炎症性疼痛,特别是减少糖解. 这一发现为减少副作用的疼痛管理提供了新的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 当前的疼痛管理策略往往会产生不良影响,影响患者的生活质量.
- 炎症性疼痛需要新的治疗目标和有效的治疗方法.
研究的目的:
- 为了研究热冲击蛋白家族A成员1A (HSPA1A) 在完整的弗洛恩德辅助剂 (CFA) 诱导的炎症性疼痛中的止痛潜力.
- 阐明HSPA1A对疼痛的影响背后的免疫调节机制.
主要方法:
- 使用了行为研究,流细胞计,转录组学,蛋白组学和细胞代谢分析.
- 在体外实验中评估了巨细胞极化和细胞因子表达.
- 通过糖解和氧化酸化测量分析了巨细胞的代谢重编程.
主要成果:
- 在CFA诱导的炎症性疼痛中,HSPA1A减轻了机械体,与巨细胞丰度相关.
- HSPA1A抑制了促炎性M1巨细胞两极分化,降低了互白素-1β (Il1b) 和瘤坏死因子 (TNF) 的表达.
- 巨细胞的新陈代谢从糖解转向氧化酸化,蛋白质表达变化.
结论:
- 通过抑制巨细胞糖解,HSPA1A具有镇痛作用,为炎症性疼痛管理提供了一种新的机制.
- HSPA1A为开发具有显著临床适用性的新型止痛药物提供了潜在的治疗标.
相关概念视频
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
Nociception
33.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.0K

